
20mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its role in glycemic control and metabolic regulation. Research has demonstrated its unique mechanism of action through simultaneous activation of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways. The 20mg formulation provides an intermediate research-grade quantity.